Pfizer Inc (PFE) stock news · P/E 39, rev $62.58B
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
This PFE news page leads with what Pfizer Inc filed — not a scraped headline mill.
No cached 8-K sentence for PFE yet. We will not pad this page with generic market recap.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 38.7.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PFE stock page; for the tape open the quote page.
PFE stock news FAQ
What are PFE's latest revenue and net income?
Latest cached Pfizer Inc (PFE) revenue for Dec 31, 2025 was $62.58B. Net income was $7.77B. Statements: https://lician.com/financials/pfe
How did PFE revenue change from the prior cached period?
Cached Pfizer Inc (PFE) revenue was down 1.6% from $63.63B (Dec 31, 2024) to $62.58B (Dec 31, 2025). Statements: https://lician.com/financials/pfe
What is PFE's P/E ratio?
Pfizer Inc (PFE) trailing P/E is 38.7 on the latest cached fundamentals snapshot.
What is PFE's market cap?
Pfizer Inc (PFE) market cap is $147.73B on the latest cached fundamentals snapshot.
What kind of company is PFE?
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE.
Where is PFE stock news listed?
Cached stock news for Pfizer Inc (PFE) is listed at https://lician.com/news/pfe. Filings: https://lician.com/sec/pfe
Not investment advice.